Erschienen in:
08.06.2020 | Brief Report
Racial Disparities in Overdose Prevention among People Who Inject Drugs
verfasst von:
Lauren Dayton, Karin Tobin, Oluwaseun Falade-Nwulia, Melissa Davey-Rothwell, Alia Al-Tayyib, Haneefa Saleem, Carl Latkin
Erschienen in:
Journal of Urban Health
|
Ausgabe 6/2020
Einloggen, um Zugang zu erhalten
Excerpt
The current opioid epidemic is the largest drug use epidemic in the history of the USA for all racial and ethnic groups [
1]. Fatal opioid overdose rates continue to be exceedingly high, with 2017 experiencing an 11% increase in opioid-related fatalities compared to 2016 and more than a 670% increase since the height of the heroin epidemic in 1975 [
1,
2]. The rise in fatal opioid overdose since the 1970s heroin epidemic has differentially affected racial groups. In the 1970s, opioid mortality was higher among Black Americans [
3,
4]. In recent years, the racial profile of opioid-related fatalities has changed and has been highest among non-Hispanic Whites, with White individuals accounting for 37,113 (78%) and Black individuals for 5513 (12%) of the 2017 opioid-related deaths [
2]. These discrepant racial trends in fatal overdose can be partially attributed to the surge in prescription opioids starting in the mid-1990s, which caused a concentrated rise in mortality among Whites while opioid-related mortality among Black individuals remained stable [
5]. This divergence is associated with well noted racial disparities in pain management and prescription patterns, with Black patients prescribed opioids at lower rates compared to all other racial/ethnic groups for almost every type of pain visit [
5]. …